SCHEMBL6129384

SCHEMBL6129384

Cc1cc2ncsc2cc1Cl

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.38
HSD17B10 Q99714 1/20 0.38
NPC1 O15118 5/20 0.37
RAB9A P51151 5/20 0.37
TDP1 Q9NUW8 2/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
KDM4E B2RXH2 2/20 0.37
HKDC1 Q2TB90 1/20 0.37
RIPK2 O43353 3/20 0.36
CD44 P16070 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
TRPM5 Q9NZQ8 1/20 0.35
POLB P06746 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35
MAPK1 P28482 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
GAA P10253 1/20 0.35
MAPT P10636 1/20 0.35
RECQL P46063 1/20 0.35
DYRK1A Q13627 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4052274 0.92 RIPK2 (0.39) ALDH1A1HSD17B10NPC1RAB9ATDP1
SCHEMBL7597205 0.83 ALDH1A1 (0.43) ALDH1A1HSD17B10NPC1RAB9ATDP1
SCHEMBL4048510 0.83 GAA (0.45) ALDH1A1HSD17B10NPC1RAB9ATDP1
SCHEMBL29414890 0.83 ALDH1A1 (0.43) ALDH1A1HSD17B10NPC1RAB9ATDP1
SCHEMBL30093444 0.83 GAA (0.45) ALDH1A1HSD17B10NPC1RAB9ATDP1
SCHEMBL1420652 0.78 GAA (0.44) ALDH1A1HSD17B10NPC1RAB9ATDP1
SCHEMBL4075601 0.76 ALDH1A1 (0.38) ALDH1A1HSD17B10NPC1RAB9ATDP1
SCHEMBL30490167 0.76 ALDH1A1 (0.38) ALDH1A1HSD17B10NPC1RAB9ATDP1
SCHEMBL22304452 0.76 DYRK1A (0.42) ALDH1A1HSD17B10NPC1RAB9ATDP1
SCHEMBL13734473 0.76 NPC1 (0.41) ALDH1A1HSD17B10NPC1RAB9ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200165519-A1 POLYMERIZABLE LIQUID CRYSTAL COMPOSITION AND RETARDATION PLATE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2020-05-28 US disclosed
US-20170335191-A1 LIQUID CRYSTAL COMPOSITION SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-11-23 US disclosed
US-20170306234-A1 LIQUID CRYSTAL COMPOSITION, METHOD OF PRODUCING THE SAME, AND RETARDATION FILM CONSTITUTED FROM THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-10-26 US disclosed
US-20170283700-A1 LIQUID CRYSTAL COMPOSITION SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-10-05 US disclosed
US-20170145312-A1 LIQUID CRYSTAL COMPOSITION SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-05-25 US disclosed
EP-1089982-A4 METHODS OF INHIBITING CORROSION USING ISOMERS OF CHLORO-METHYLBENZOTRIAZOLE BETZDEARBORN INC (US) 2005-04-06 EP disclosed
EP-1089982-A1 METHODS OF INHIBITING CORROSION USING ISOMERS OF CHLORO-METHYLBENZOTRIAZOLE BetzDearborn Inc (US) 2001-04-11 EP disclosed
WO-1999067222-A1 METHODS OF INHIBITING CORROSION USING ISOMERS OF CHLORO-METHYLBENZOTRIAZOLE BETZDEARBORN INC. (US) 1999-12-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170335191-A1 LIQUID CRYSTAL COMPOSITION RCC1, CCDC47, ACIN1 ALDH1A1 4362/4885HSD17B10 2059/4885NPC1 2687/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.